University of the Philippines
32
2
2
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
9.4%
3 terminated/withdrawn out of 32 trials
85.0%
-1.5% vs industry average
44%
14 trials in Phase 3/4
6%
1 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Role: collaborator
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
Role: lead
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
Role: lead
The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study
Role: lead
MLC901 in Moderate Traumatic Brain Injury
Role: lead
Dengue Serostatus Study in the Philippines
Role: lead
Dengue Effectiveness Study in the Philippines
Role: lead
COVID-19 Effectiveness Study in the Philippines
Role: lead
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19
Role: lead
Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients
Role: lead
Public Health Emergency: SOLIDARITY TRIAL Philippines
Role: lead
Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19
Role: lead
Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study
Role: lead
Performance, Safety, and Efficacy of a New Cyrotherapy Device for Cervical Dysplasia
Role: collaborator
Iron-Biofortified Rice Intervention in the Philippines
Role: collaborator
The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial
Role: lead
Neurologic Manifestations of COVID-19
Role: lead
Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants
Role: lead
Use of Banana Leaf Dressing on Donor Site Wounds
Role: lead
Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI)
Role: lead